Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Vulva”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00905658
What this trial is testing

Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer

Who this might be right for
Cervical CancerEndometrial CancerFallopian Tube Cancer+4 more
Centre Oscar Lambret 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT03403465
What this trial is testing

Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal Cancers

Who this might be right for
Cancer of the CervixVulvar CancerEsophageal Cancer+1 more
Duke University 90
Not applicableLooking for participantsNCT05743517
What this trial is testing

Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)

Who this might be right for
Ovary CancerEndometrial CancerUterine Cancer+4 more
Northwestern University 192
Large-scale testing (Phase 3)Ended earlyNCT00006096
What this trial is testing

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer of the Vulva

Who this might be right for
Vulvar Cancer
Gynecologic Oncology Group
Large-scale testing (Phase 3)Active Not RecruitingNCT05662020
What this trial is testing

Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China

Who this might be right for
Human Papillomavirus Infection
Beijing Health Guard Biotechnology, Inc 2,750
Large-scale testing (Phase 3)Study completedNCT01245764
What this trial is testing

GARDASIL™ Study in Healthy Females Between 9 and 26 Years of Age in Sub-Saharan Africa (V501-046)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 250
Testing effectiveness (Phase 2)Active Not RecruitingNCT02628067
What this trial is testing

Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)

Who this might be right for
Advanced CancerAnal CarcinomaAnal Cancer+22 more
Merck Sharp & Dohme LLC 1,609
Not applicableNot Yet RecruitingNCT06582108
What this trial is testing

UNDERSTANDING the RAREST GYNECOLOGICAL CANCERS: a MULTI -OMICS PLATFORM for IMPROVED PATIENTS MANAGEMENT

Who this might be right for
Uterine SarcomaVulvar CancerNon Epithelial Ovarian Cancers (NEOC)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 190
Early research (Phase 1)Looking for participantsNCT04169763
What this trial is testing

Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery

Who this might be right for
Stage II Vulvar Cancer AJCC v8Stage III Vulvar Cancer AJCC v8Stage IIIA Vulvar Cancer AJCC v8+3 more
M.D. Anderson Cancer Center 25
Not applicableStudy completedNCT03346915
What this trial is testing

Integrating a Health Information Technology System for Primary and Secondary Cervical Cancer Prevention

Who this might be right for
Human Papilloma VirusCervical CancerHuman Papillomavirus Infection+5 more
Boston Medical Center 60
Testing effectiveness (Phase 2)Ended earlyNCT04066894
What this trial is testing

Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE Study

Who this might be right for
Low Anterior Resection SyndromeMalignant Anal NeoplasmMalignant Bladder Neoplasm+8 more
M.D. Anderson Cancer Center 3
Large-scale testing (Phase 3)Study completedNCT00033605
What this trial is testing

Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis

Who this might be right for
Cervical CancerColorectal CancerDiarrhea+8 more
Alliance for Clinical Trials in Oncology 130
Testing effectiveness (Phase 2)UnknownNCT05051696
What this trial is testing

Intra-tumor Injection of Oncolytic Viruses H101 Combined With or Without Radiotherapy in Refractory/Recurrent Gynecological Malignancies

Who this might be right for
Genital Neoplasms, Female
Liu Zi 120
Large-scale testing (Phase 3)Study completedNCT02997553
What this trial is testing

Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery

Who this might be right for
Breast CarcinomaHead and Neck CancerMelanoma (Skin)+7 more
Institut de Cancérologie de Lorraine 744
Not applicableStudy completedNCT03339765
What this trial is testing

Self-Advocacy Serious Game in Advanced Cancer

Who this might be right for
Ovarian Cancer Stage IIIOvarian Cancer Stage IVBreast Cancer Stage IV+10 more
University of Pittsburgh 78
Large-scale testing (Phase 3)Study completedNCT01047345
What this trial is testing

V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006)

Who this might be right for
Cervical CancersVulvar CancersVaginal Cancers+1 more
Merck Sharp & Dohme LLC 924
Not applicableUnknownNCT00956670
What this trial is testing

Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer

Who this might be right for
LymphedemaStage IA Cervical CancerStage IA Uterine Corpus Cancer+11 more
Gynecologic Oncology Group 1,055
Testing effectiveness (Phase 2)Looking for participantsNCT06975410
What this trial is testing

Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors

Who this might be right for
EGFR OverexpressionLocally Advanced Solid TumorMetastatic Solid Tumor
Yuhan Corporation 80
Testing effectiveness (Phase 2)WithdrawnNCT03220009
What this trial is testing

Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma

Who this might be right for
Cervical CarcinomaEsophageal CarcinomaMucosal Melanoma+14 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT00288821
What this trial is testing

Diagnostic Imaging of Lymph Nodes in Gynaecologic Oncology

Who this might be right for
Cervix NeoplasmsOvarian NeoplasmsEndometrial Neoplasms+2 more
UMC Utrecht 84
Next Page